<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379648</url>
  </required_header>
  <id_info>
    <org_study_id>10477M-TEDI</org_study_id>
    <nct_id>NCT04379648</nct_id>
  </id_info>
  <brief_title>Assessment of Dissociative Traumatic Disorders</brief_title>
  <acronym>TEDI</acronym>
  <official_title>Assessment of Dissociative Traumatic Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Januel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de Ville-Evrard, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This
      disorder, as well as all the disorders on the dissociation spectrum, must therefore be
      clarified and better diagnosed.

      The goal of this research is :

        1. to assess the prevalence of dissociative disorders using specific tools in patients
           suffering from PTSD.

        2. to validate the French version of the DDIS interview (Ross, 1997) that the investigators
           have translated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2019</start_date>
  <completion_date type="Anticipated">September 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients with a diagnosis of Post Traumatic Stress Disorder will be seen by a physician psychiatrist or psychologist who will introduce them to the study. They will be given an information letter and a consent form. If patients agree to participate in the study, and after signing the consent form, they will be included and will complete the assessment scales.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Traumatic Stress</measure>
    <time_frame>1 year</time_frame>
    <description>assessment of the prevalence of dissociative disorders in a cohort of patients with PTSD</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Posttraumatic stress disorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cohort of patients with Posttraumatic stress disorder PTSD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>self-assessment and hetero-assessment</intervention_name>
    <description>Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview</description>
    <arm_group_label>Posttraumatic stress disorder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient diagnosed with PTSD according to DSM 5 criteria

          -  Over 18 years of age

          -  Informed consent signed

        Exclusion Criteria:

          -  Neurological disorders

          -  Serious and/or unstable somatic pathologies

          -  Patient not affiliated with social security

          -  Patient hospitalized under restraint in psychiatric care by decision of the state
             representative or in psychiatric care at the request of a third party

          -  Patient under guardianship

          -  Patient participating in parallel in another biomedical research

          -  Change of antidepressant in the last three months

          -  Patient not mastering the French language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid KALALOU, Psychiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>EPS Ville Evrard</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BENCHERIF Youcef, CRA</last_name>
    <phone>0143093030</phone>
    <email>y.bencherif@epsve.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rusheenthira THAVASEELAN, CRA</last_name>
    <phone>0143093030</phone>
    <email>r.thavaseelan@epsve.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Youcef BENCHERIF</name>
      <address>
        <city>Neuilly Sur Marne</city>
        <state>ÃŽle De France</state>
        <zip>93330</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youcef BENCHERIF, CRA</last_name>
      <phone>0143093030</phone>
      <email>y.bencherif@epsve.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre hospitalier de Ville-Evrard, France</investigator_affiliation>
    <investigator_full_name>Januel</investigator_full_name>
    <investigator_title>Clinical research unit manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

